46

DAFTAR PUSTAKA

B. D. Schoub (1999). AIDS and HIV in Perspective: A Guide to Understanding the Virus and Its Consequences. Cambridge University Press. 57-59.

Bica I, McGovern B, Dhar R (2001). Increasing Mortality Due to End-stage Liver Disease in Patients with Human immunodeficiency Virus Infection. Clin Infect Dis 2001;32:492-7.

Brooks, G.F., Butel, J.S., Morse, S.A (2008). AIDS dan Lentivirus. Dalam: Brooks, Butel, Morse. Jawetz, Melnick, & Adelbergs Mikrobiologi Kedokteran 23rd Ed. Jakarta: EGC. 617-32.

Michael W. Davidson (2005). The Human Immunodeficiency Virus (HIV). The Florida State University.

De Maat M, Mathot R, Veldkamp A, Huitma A, Mulder J, Meenhorst P, et al (2002). Hepatotoxicity Following Nevirapine Containing Regimens in HIV-1-Infected Individuals. Pharmacol Res 46:295-300.

Departemen Kesehatan Republik Indonesia (2006). Pedoman Pelayanan Kefarmasian Untuk Orang Dengan HIV/AIDS (ODHA). Direktorat Bina Farmasi Komunitas dan Klinik Depkes RI.

Departemen Kesehatan Republik Indonesia (2007). Pedoman Nasional Terapi Antiretroviral; Pedoman Tatalaksana Klinis dan Infeksi HIV pada Orang Dewasa dan Remaja, Edisi Kedua.

Departemen Kesehatan Republik Indonesia (2011). Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral Pada Orang Dewasa. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan Depkes RI.

Dinas Kesehatan Provinsi Kepulauan Riau (2012). Profil Kesehatan Provinsi Kepulauan Riau Tahun 2012.

Ditjen PPM & PL Depkes RI (2013). Statistik Kasus HIV/AIDS di Indonesia Dilapor s/d Desember 2013.Jakarta:Departemen Kesehatan RI.

Djoerban, Zubairi (2007). HIV/AIDS di Indonesia. Dalam: Aru W. Sudoyo. Buku Ajar Ilmu Penyakit Dalam, Jilid III, Edisi IV. Jakarta: FKUI.

Faucy, Anthony S., dan Lane, H. Clifford (2008). Human Immunodeficiency Virus Disease: AIDS and Related Disorder. Dalam: A.S. Fauci. Harissons Principles of Internal Medicine, 17th ed [e-book]. New York: McGraw-Hill. Chap.182.

Felissa R. Lashley, Jerry D. Durham (2009). The Person With HIV/AIDS: Nursing Perspectives. Springer Publishing Company.

Harvey, Richard (2007). Retrovirus and AIDS. Dalam: Richard A Harvey. Microbiology 2nd Edition [e-book]. Baltimore: Lippincott Williams & Wilkins. 295-303.

Havlir DV, Currier JS (2003). Complications of HIV infection and antiretroviral therapy.Top HIV Med.;11:8691.

Hernandez L, Gilson I, Jacobson J, Affi A, Puetz T, Dindzans V (2001). Antiretroviral Hepatotoxicity in HIV-Infected Patients. Aliment Pharmacol Ther. 15:1627-1632.

Highleyman L (2012). Liver Toxicity Uncommon with Modern Antiretroviral Drugs, but Hugher Risk for HIV/HCV Coinfected.

Hooshyar D, Napravnik S, Miller W, Eron J (2006). Effect of Hepatitis C co-Infection on Discontinuitatum and Modification of Initial HAART in Primary HIV Care. AIDS.

Jawetz M; Adelbergs (2005). Mikrobiologi Kedokteran. edisi 23. Alih Bahasa: Huriwati Hartanto dkk. Jakarta, Penerbit Buku Kedokteran ECG.

Johnshon S, Chan J, Bennett C (2002). Hepatotoxicity After Prophylaxis With a Nevirapine-Containing Antiretroviral Regimen. Ann Intern Med. 137:146-147.

Kalyesubula R, Kagimu M, Opio KC (2011). Hepatotoxicity from FirstLine Antiretroviral Theraphy: an Experience from a Resource Limited Setting. African Health Science. 11(1): 1623

Kathryn M Chu,Andrew M Boulle,Nathan Ford (2010). Nevirapine-Associated Early Hepatotoxicity: Incidence, Risk Factors, and Associated Mortality in a Primary Care ART Programme in South Africa. South African Medical Unit, Mdecins Sans Frontires, Johannesburg, South Africa.

Katzung, B (2004). Basic and Clinical Pharmacology, 8th Edition; 1130-1155, USA; Mc.Graw Hill Companies.Inc.

Kee, Joyce LeFever (2008). Pedoman Pemeriksaan Laboratorium dan Diagnostik. Jakarta : EGC.

Kementrian Kesehatan Republik Indonesia (2011). Pedoman Interpretasi Data Klinik. Direktorat Bina Pelayanan Kefarmasian dan Alat Kesehatan Kemenkes RI.

Kumar V, Cotran RS, Robbins SL (2007). Buku Ajar Patologi. 7th ed , Vol. 1. Jakarta: Penerbit Buku Kedokteran EGC.

Lapau, Buchari (2012). Metode Penelitian Kesehatan. Jakarta: Yayasan Pustaka Obor.

Lee WM (2003). Drug-induced hepatotoxicity. N Engl J Med; 349:47485.

Leith J, Piliero P, Storfer S, Mayers D, Hinzmann R (2005). Appropriate Use of Nevirapine for Long-Term Therapy. J Infect Dis.1;192(3): 545-6.

Murphy, R (2003). Defining the Toxicity Profile of Nevirapine and Other Antiretroviral Drugs. Journal of Acquired Immune Deficiency Syndrome; 34;S15-20.

Notoadmodjo, Soekidjo (2010). Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta.

Nunez MJ. Martin-Carbonero L, Moreno V, Valencia E, Gracia-Samaniego J, et al (2006). Impact of Antiretroviral Treatment-Related Toxicities on Hospital Admissions in HIV-Infected Patients. AIDS Res Hum Retroviruses. 22:825-829.

P2PL Dinas Kesehatan Kota Batam (2010). Kejadian Kasus HIV & AIDS dan Kematian HIV &AIDS di Kota Batam Tahun 2006-2009.

Palella F, Baker R, Moorman A, Chmiel J, Brooks J, et al (2006). Mortality in The Highly Active Antiretroviral Therapy Era: Changing Causes of Death And Desease in The HIV Outpatient Study. J Acquired Immune Deficiency Syndrome., 43: 27-34.

Podolsky, Isselbacher (2002). Tes Diagnostik pada Penyakit Hati. Dalam: Harrison Prinsip-prinsip Ilmu Penyakit Dalam. Edisi 13. Volume 4. Jakarta :Penerbit Buku Kedokteran EGC

Pollard RB, Robinson P, Dransfield K (1998). Safety Profile of Nevirapine, A Nonnucleoside Reverse Transcriptase Inhibitor for The Treatment of Human Immunodeficiency Virus Infection. Clin Ther. 20(6): 1071-92.

Ramadian, O (2010). Pengaruh Efek Samping Antiretroviral Lini Pertama Terhadap Adherens ODHA di Layanan Terpadu Rumah Sakit Cipto Mangunkusumo Jakarta, Podiksus HIV/AIDS.

Sacher, McPerson (2002). Tinjauan Klinis Hasil Pemeriksaan Laboratorium. Edisi 11. Jakarta : Penerbit Buku Kedokteran EGC.

Sanne I, Mommeja-Marin H, Hinle J, Bartlett J, Lederman M, Maartens G, et al (2005). Severe Hepatotoxicity Associated With Nevirapine Use in HIV-Infected Subjects. J Infect Dis 2005; 191;825-829.

Siswanto, dkk (2013). Metodologi Penelitian Kesehatan dan Kedokteran. Yokyakarta : Bursa Ilmu.

Sulkowski MS (2004). Drug-induced Liver Injury Associated with Antiretroviral Therapy that Includes HIV-1 Protease Inhibitors. Clin Infect Dis; 38:90-97.

WHO. Global Summary of the AIDS Epidemic (2012). Dalam: Core Epidemiological Slides HIV/AIDS Estimates WHO. 2013 [ diakses Juli 2014].http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/201309_epi_core_en.pdf

Wit FW, Weverling GJ, Weel J, Jurriaans S, Lange JM (2002). Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination Therapy. J Infect Dis. 1; 186(1): 23-31.

Wood E, Hogg RS, Yip, Harigan PB (2003). Effect of Medication Adherence on Survival of HIV Patient Who Start HAART When CD4+ cell Count 200-240 cell/L. Ann Intern Med.

Wondemagegn M, Gidey B,Chernet A,Alem G,Abera B (2013). Hepatotoxicity and associated risk factors in HIV-infected patients receiving antiretroviral therapy at Felege Hiwot Referral Hospital, Bahirdar, Ethiopia. Ethiop J Health Sci.:217-26.42